Iboga &amp; Plant Medicine Blog

5-MeO-DMT Near Me: Where North Americans Actually Access It

5-MeO-DMT does not exist near you if you are in the United States. It is Schedule I at the federal level. For most North Americans, the closest legal access is Vancouver, BC — 45 minutes from the Washington border — and the question shifts from legality to whether you are an appropriate candidate.

August 4, 2026Read →

Iboga vs DMT: What the Difference Actually Is

Iboga and DMT are not versions of the same thing. Iboga is a 12–24 hour whole-plant ceremony from Central Africa. N,N-DMT is a single tryptamine compound, active for 5–20 minutes when smoked. The mechanisms, the traditions, and the appropriate candidate profiles are entirely different.

August 3, 2026Read →

Ibogaine Treatment Facilities: What a Legitimate Centre Must Have

Ibogaine treatment facilities are not regulated by any certifying body. There is no inspection process, no minimum safety standard enforced by an external authority, and no licensing requirement that distinguishes a centre with continuous cardiac monitoring from one without it. What you ask before agreeing to anything determines the outcome.

August 2, 2026Read →

5-MeO-DMT Retreat Cost: What the Price Covers

A 5-MeO-DMT retreat in Canada costs $600–$1,500 CAD at providers maintaining appropriate safety standards. The variation is not about location or aesthetics — it reflects what the programme includes. Shorter than ibogaine does not mean lighter.

August 1, 2026Read →

Best Ibogaine Treatment Centers: What That Ranking Actually Means

When you search for the best ibogaine treatment centers, most rankings measure amenities and testimonials. The criteria that determine whether a center is safe are clinical — mandatory EKG, on-site physician, continuous cardiac monitoring, and integration support that is not optional.

July 31, 2026Read →

The Iboga Experience: What Whole-Plant Ceremony Actually Involves

The iboga experience uses whole-plant root bark — not isolated ibogaine HCl — and the distinction changes the preparation required, the progression of the experience, and what comes after. It runs 12–24 hours. It is not comfortable. And integration is not optional.

July 30, 2026Read →

Bufo Toads and 5-MeO-DMT: Conservation, Venom, and the Case for Synthetic

Bufo toads — Incilius alvarius, the Sonoran Desert toad — produce venom containing 5-MeO-DMT at 15–25% concentration by dry weight. Ceremonial demand has grown faster than wild populations can sustain. Laboratory-synthesized 5-MeO-DMT is molecularly identical. Responsible providers use synthetic.

July 29, 2026Read →

Ayahuasca and Iboga: How They Differ and When Both Are Used

Ayahuasca and iboga come from different continents, work through different neurological mechanisms, and cannot be used together safely. Understanding what each does — and does not do — is the starting point for anyone researching both medicines.

July 28, 2026Read →

Ibogaine Treatment in Canada: Legal Access, Cost, and What to Expect

Ibogaine treatment in Canada is accessible without the legal restrictions that have blocked it in the United States since 1970. What that access actually involves — cost in CAD, medical requirements, travel from the US border, and who cannot proceed.

July 27, 2026Read →

Ibogaine Cost: What the Price Covers and What Cheap Providers Are Cutting

Ibogaine cost at Transcend in Vancouver, BC ranges from $2,000–$5,000 CAD. The variation is not random — it reflects what is, and is not, included in the price. The components that drive the higher end of that range are also the ones that determine whether the ceremony is medically safe.

July 26, 2026Read →

Integration9 min

Psychedelic Meditation: Preparation, Ceremony, and Integration

Psychedelic meditation covers three distinct contexts: preparing for ceremony, staying present during it, and integrating what the medicine reveals afterward. None of these is the same thing — and integration is the part most likely to determine whether anything lasting results.

July 25, 2026Read →

How Is Ibogaine Administered? Methods, Dosing, and Medical Monitoring

Ibogaine is administered orally — in capsules of the hydrochloride salt, under continuous cardiac monitoring by an on-site physician. The dose is calculated by body weight. This is how it is done safely. Providers who skip the monitoring are not cutting costs. They are removing the safeguard.

July 23, 2026Read →

Ibogaine Treatment Near Me: Where North Americans Actually Access It

Ibogaine treatment does not exist near you if you are in the United States. The medicine has been Schedule I since 1970. For most North Americans, the nearest legal access is Vancouver, BC — 45 minutes from the Washington border. What that involves, what it costs, and who is not a candidate.

July 22, 2026Read →

Books on Psychedelics Worth Reading — and What They Leave Out

The best books on psychedelics give you context and honest accounts of what these medicines produce. None of them will tell you whether your heart is safe for ibogaine. Both kinds of knowledge matter.

July 20, 2026Read →

Research9 min

Psychedelic Therapy Research: What the Evidence Shows

The Stanford ibogaine study recorded 88% reductions in PTSD symptoms at one month. The Texas clinical trials have committed $50 million to follow-up research. Neither number tells you whether this treatment is appropriate for you specifically.

July 19, 2026Read →

Iboga vs Ayahuasca: Different Plants, Different Traditions

Iboga comes from the rainforests of Gabon. Ayahuasca comes from the Amazon basin. Both address trauma, addiction, and depression — through different mechanisms, at different durations, with different demands. Neither is a substitute for the other.

July 18, 2026Read →

Is Ibogaine Legal in the USA? Legal Status by Country

Ibogaine has been Schedule I in the United States since 1970. No US state has created an exemption. For Americans who want legal access, Canada is 45 minutes from the border — and the question becomes not legality, but whether the specific provider is operating safely.

July 17, 2026Read →

Psychedelic Facilitator Training: What It Covers and What It Doesn't Guarantee

Psychedelic facilitator training has no universal standard and no licensing body. What the best programmes teach, what direct experience and lineage provide that no curriculum can, and why the most important qualification a facilitator can have is what infrastructure they have in place when something goes wrong.

July 16, 2026Read →

Ibogaine Treatment Near Seattle: Your Nearest Legal Option

Ibogaine treatment doesn't exist in Seattle. It doesn't exist anywhere in the United States — the medicine has been Schedule I since 1970. Vancouver, BC is 2.5 hours north by car, and the medical screening requirements are the same regardless of where you cross from.

July 15, 2026Read →

Ibogaine Retreat: What a Legitimate Programme Actually Includes

An ibogaine retreat is not a wellness experience. The ceremony runs 12–24 hours. The recovery period that follows requires medical supervision. The weeks after departure determine whether any lasting change results.

July 14, 2026Read →

Ibogaine and 5-MeO-DMT: A Combined Treatment Programme

Ibogaine and 5-MeO-DMT are not alternatives. Ibogaine works through 12–24 hours of narrative memory review. 5-MeO-DMT works through 20–45 minutes of ego dissolution. For some people, the second completes what the first starts.

July 13, 2026Read →

Bwiti Spiritual Tradition: Origins, Iboga, and Ceremony

Bwiti is not a synonym for ibogaine treatment. It is a living initiatory tradition from Gabon and Cameroon in which iboga is the sacrament — used not for symptom reduction, but to confront what a person has been avoiding.

July 12, 2026Read →

Ibogaine Treatment Centers: What Legitimate Centres Include

Ibogaine treatment centers are not regulated by any certifying body. The medical infrastructure each center includes — or omits — is the only reliable standard for whether it operates safely.

July 11, 2026Read →

Iboga in Canada: Legal Status, Providers, and What to Expect

Iboga is legally accessible in Canada. What the unscheduled status enables, what it does not guarantee, and what medical infrastructure every legitimate Canadian provider must have in place before confirming any ceremony date.

July 10, 2026Read →

Ibogaine Treatment Cost: What You Actually Pay

Ibogaine treatment cost in Canada is $2,000–$5,000 CAD — covering the on-site physician, continuous cardiac monitoring, the medicine, and facilitation. The price difference between providers is not about amenities. It reflects what safety infrastructure has been removed.

July 9, 2026Read →

Conor McGregor, Ibogaine, and What the Headlines Don't Cover

Conor McGregor's public statements about ibogaine brought more mainstream attention to the medicine than six decades of clinical research had managed. They also produced a version of the story that omits cardiac screening, medical monitoring, and the integration work that determines whether any lasting change results.

July 8, 2026Read →

Ibogaine Treatment in the US: Legal Status, Access, and Alternatives

Ibogaine treatment is not available inside the United States. It has been Schedule I since 1970 — classified before the clinical research existed. Where Americans access treatment legally, what US trials are now doing, and who is not a candidate.

June 23, 2026Read →

The Ibogaine Experience: What Happens in the 12–24 Hours

The ibogaine experience is not a recreational altered state. It unfolds across three phases over 12–24 hours. The first is visual and confrontational. The second is introspective and physically demanding. The third determines whether anything lasting comes from the first two.

June 22, 2026Read →

Iboga Root: What It Is, What It Contains, and Who It Is Not For

Iboga root is the source of ibogaine — but the root bark contains more than 30 alkaloids, not one. What those alkaloids do, why the whole plant differs from the isolated extract, and who is not an appropriate candidate for either.

June 21, 2026Read →

Addiction9 min

Ibogaine for Sex Addiction: What the Research Shows

Ibogaine acts on the same reward-circuit disruption underlying compulsive sexual behavior as it does in substance addiction. The evidence for behavioral addiction is thinner than for opioid dependence — and the contraindications are identical.

June 20, 2026Read →

Ibogaine Treatment Cost in Mexico: What You Actually Pay

Ibogaine treatment in Mexico costs $4,000–$12,000+ USD depending on medical infrastructure. The price spread is not about amenities — it reflects how much safety has been reduced. What the price should cover, red flags to watch for, and who should not pursue this at any price point.

June 16, 2026Read →

What to Expect at an Ibogaine Treatment Centre

An ibogaine treatment centre is not a wellness retreat. The ceremony runs 12–24 hours. The medical screening beforehand determines whether it is safe for you specifically. Here is what the full process actually looks like.

June 15, 2026Read →

Education12 min

Bufo Retreat: What It Is, What Happens, and What It Costs

A bufo retreat is not a long experience — the active 5-MeO-DMT phase lasts 20–45 minutes. The 2–3 day recovery and the integration work that follows are what determine whether anything lasting comes from it.

June 15, 2026Read →

The Bufo Experience: What Happens in 20–45 Minutes

The bufo experience lasts 20–45 minutes. The ego dissolution it produces is not subtle, and shorter does not mean gentler — the absence of narrative content makes integration harder, not simpler.

June 14, 2026Read →

Psychedelic Plants: Iboga, Ayahuasca, Psilocybin and 5-MeO-DMT

Not all psychedelic plants are interchangeable. Iboga works through opioid receptors and GDNF pathways. Ayahuasca contains MAO inhibitors that make combining it with other medicines dangerous. The mechanism determines the appropriate candidate — and the conditions that actually respond.

June 14, 2026Read →

Research9 min

What Does Ibogaine Do to the Brain? The Neuroscience Explained

Ibogaine acts on four distinct receptor systems at once. The opioid withdrawal stops within hours. The GDNF-driven neuroplastic changes — visible in brain scans — unfold over weeks and determine whether anything lasting follows.

June 13, 2026Read →

Research10 min

Ibogaine Success Rate: What the Research Actually Shows

There is no single ibogaine success rate. What exists is a body of research with specific numbers, specific populations, and specific follow-up periods — and a long-term outcome that depends more on the weeks after ceremony than on the ceremony itself.

June 13, 2026Read →

Ibogaine Contraindications: The Complete List

Some contraindications are absolute. Some require preparation. The distinction matters — because the most common one (SSRIs) is not a permanent disqualifier, while cardiac arrhythmia is.

June 12, 2026Read →

Iboga Microdosing: What It Is, How It Works, and What the Research Shows

Iboga microdosing is not a safer version of a flood dose. It is a different approach — with different applications, a weaker evidence base, and the same cardiac contraindications. What the research actually shows, and who should not attempt it.

June 12, 2026Read →

Education11 min

What Is the Bufo Frog? The Sonoran Desert Toad and 5-MeO-DMT

The bufo frog is Incilius alvarius — the Sonoran Desert toad. Its venom contains 5-MeO-DMT at 15–25% concentration. The active experience lasts 20–45 minutes. The integration period determines whether any lasting change follows.

June 12, 2026Read →

Research9 min

Ibogaine for PTSD: What the Research Shows

The 2023 Stanford study found 88% reductions in PTSD symptoms at one month in 30 special operations veterans. The mechanism is distinct from every current treatment. So are the contraindications — and the people who most urgently want this are not always appropriate candidates.

June 11, 2026Read →

Addiction10 min

Ibogaine and Alcohol: How It Works, What the Research Shows

Ibogaine interrupts alcohol dependence through a specific GDNF mechanism that no other treatment directly addresses. The evidence is consistent. So are the contraindications — including one that is specific to alcohol-dependent candidates and that has killed people when ignored.

June 11, 2026Read →

How to Get Ibogaine Treatment: Access, Screening, and Cost

Ibogaine treatment is accessible in Canada — it is not listed under the Controlled Drugs and Substances Act. Getting it safely means passing cardiac screening, understanding what the process involves, and being honest about whether you are an appropriate candidate.

June 10, 2026Read →

Education11 min

Ibogaine vs Ketamine: What the Difference Actually Is

Ibogaine and ketamine both show real results for treatment-resistant depression. They work through different mechanisms and serve different populations. The choice between them is not a matter of preference.

June 10, 2026Read →

Iboga Ceremony: What It Is, How It Works, and Who Cannot Attend

An iboga ceremony is not a psychedelic retreat in the wellness sense. The active experience runs 12–24 hours. The medicine tends to show people what they have been avoiding — not what they came to find.

June 9, 2026Read →

Iboga Retreat: What It Is, What Happens, and Who It Is Not For

An iboga retreat is not a weekend workshop. The active ceremony runs 12–24 hours. Recovery takes 2–3 days. The noribogaine that follows influences mood and craving for weeks. What you do with that window determines the outcome.

June 9, 2026Read →

Research10 min

Ibogaine for Depression and Anxiety: What the Research Shows

Ibogaine addresses depression and anxiety through mechanisms distinct from antidepressants. The 2023 Stanford study found 87% reductions in depression symptoms at one month — in a population where conventional treatment had not worked. Who this is for, and who it is not.

June 8, 2026Read →

Education8 min

5-MeO-DMT vs DMT: What the Difference Actually Is

5-MeO-DMT and DMT share a chemical lineage. The experiences they produce are not comparable. Understanding the difference matters for anyone considering either medicine for depression, trauma, or addiction.

June 8, 2026Read →

Ibogaine vs Mushrooms: What the Difference Actually Is

Ibogaine and psilocybin mushrooms are often named in the same conversation about psychedelic therapy. They operate through different mechanisms, serve different populations, and have different safety requirements. The choice between them is not a matter of preference.

June 7, 2026Read →

Research11 min

Psychedelics in Recovery: What the Research Actually Shows

Psychedelics in recovery is not a single treatment category. Ibogaine resets opioid receptor physiology in a way no other substance approaches. The distinctions between medicines — and between appropriate and inappropriate candidates — matter.

June 7, 2026Read →

Guide7 min

How Long Does Ibogaine Last? Duration, Phases, and Recovery

The active ibogaine experience runs 12–24 hours. Recovery takes 2–3 days. Noribogaine, the active metabolite, influences mood and craving for weeks to months — which is the part that determines whether any lasting change comes from it.

June 6, 2026Read →

Iboga vs Ibogaine: The Difference Between Plant and Alkaloid

Iboga is the plant. Ibogaine is one alkaloid extracted from it. The choice between whole-plant preparations and isolated ibogaine is not just chemical — it is contextual, and it matters for what to expect from either.

June 6, 2026Read →

Why Is Ibogaine Illegal in the US? The Legal Status Explained

Ibogaine is illegal in the United States because of a scheduling decision made in 1970 — not because of clinical evidence, which did not exist at the time. The research that now exists has not changed the schedule.

June 6, 2026Read →

Bufo Ceremony: What It Is, What Happens, and What It Costs

A bufo ceremony is 20–45 minutes of acute ego dissolution, a 2–3 day recovery period, and an integration process that determines whether anything lasting comes from it. It is not a gentle introduction to plant medicine.

June 5, 2026Read →

Ibogaine vs Ayahuasca: What the Difference Actually Is

Ibogaine and ayahuasca are often treated as interchangeable by people who have heard of both. They are not. The mechanisms are different, the experiences are different, and the conditions each addresses most effectively are different.

June 4, 2026Read →